Last reviewed · How we verify
Shepherd's Purse extractum oleosum vagitories
Shepherd's Purse extractum oleosum vagitories is a Small molecule drug developed by University of Sarajevo. It is currently FDA-approved.
At a glance
| Generic name | Shepherd's Purse extractum oleosum vagitories |
|---|---|
| Sponsor | University of Sarajevo |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Shepherd's Purse extractum oleosum vagitories CI brief — competitive landscape report
- Shepherd's Purse extractum oleosum vagitories updates RSS · CI watch RSS
- University of Sarajevo portfolio CI
Frequently asked questions about Shepherd's Purse extractum oleosum vagitories
What is Shepherd's Purse extractum oleosum vagitories?
Shepherd's Purse extractum oleosum vagitories is a Small molecule drug developed by University of Sarajevo.
Who makes Shepherd's Purse extractum oleosum vagitories?
Shepherd's Purse extractum oleosum vagitories is developed and marketed by University of Sarajevo (see full University of Sarajevo pipeline at /company/university-of-sarajevo).
What development phase is Shepherd's Purse extractum oleosum vagitories in?
Shepherd's Purse extractum oleosum vagitories is FDA-approved (marketed).